This study investigates the efficacy of
carnosic acid (CA), a polyphenolic
diterpene, isolated from the plant rosemary (Rosemarinus officinalis), on
androgen-independent human
prostate cancer PC-3 cells. CA induced anti-proliferative effects in PC-3 cells in a concentration- and time-dependent manner, which was due to apoptotic induction as evident from flow-cytometry,
DNA laddering and TUNEL assay. Apoptosis was associated with the activation of
caspase-8, -9, -3 and -7, increase in Bax:Bcl-2 ratio, release of
cytochrome-c and decrease in expression of inhibitor of apoptosis (IAP) family of
proteins. Apoptosis was attenuated upon pretreatment with specific inhibitors of
caspase-8 (
Z-IETD-fmk) and
caspase-9 (
Z-LEHD-fmk) suggesting the involvement of both intrinsic and extrinsic apoptotic cascades. Further, apoptosis resulted from the inhibition of IKK/NF-κB pathway as evident from decreased
DNA binding activity, nuclear translocation of p50 and p65 and IκBα phosphorylation. The down-regulation of IKK/NF-κB was associated with inhibition of Akt phosphorylation and its
kinase activity with a concomitant increase in the
serine/
threonine protein phosphatase 2A (PP2A) activity. Pharmacologic inhibition of PP2A by
okadaic acid and
calyculin A, significantly reversed CA-mediated apoptotic events in PC-3 cells indicating that CA induced apoptosis by activation of PP2A through modulation of Akt/IKK/NF-κB pathway. In addition, CA induced apoptosis in another
androgen refractory
prostate cancer DU145 cells via intrinsic pathway as evidenced from the activation of
caspase 3, cleavage of PARP, increase in Bax:Bcl-2 ratio and
cytochrome-c release.
Carnosic acid, therefore, may have the potential for use in the prevention and/or treatment of
prostate cancer.